Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology. By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds by fermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow. Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.

Liaoning Chengda Biotechnology Co., Ltd. is an international advanced virus vaccine production technology platform introduced from the United States. It was established in Shenyang in June 2002 as a high-tech enterprise. Companies adhering to the "integrity integrity, benevolence and harmony" of the core values, is committed to research and development, production and promotion of "international level, domestic leading" biological products, the main products for Chengda speed up human rabies vaccine and Chengda Libao people type B Encephalitis inactivated vaccine. Chengda Bio was listed on the New Third Board on December 31, 2014 with a registered capital of 360 million. It is controlled by Liaoning Chengda Co., Ltd. (600739), and its profitability and appreciation potential are among the top three new board companies. The production base is located in the National High-tech Park of Weinan, Shenyang, covering an area of ​​nearly 100 acres, with a construction area of ​​over 50,000 square meters and more than 800 employees. There are 4 stock solutions workshops, 3 preparation workshops and a pilot plant. The annual production capacity of human rabies vaccine reaches 10 million, and the annual production capacity of Japanese encephalitis vaccine is 10 million. All workshops have successfully passed the 2010 national new GMP certification. Chengda Bio is a family vaccine manufacturer. Chengda Suida rabies vaccine has always maintained a leading position in the domestic market, and has been exported to India, Pakistan, Thailand, the Philippines, Kenya, Ghana, Malawi, Georgia, etc. Countries. Chengda Libao JE vaccine is currently the only inactivated Japanese encephalitis vaccine in China and has been successfully exported to Thailand and registered in Cambodia. The bivalent renal syndrome hemorrhagic fever vaccine (Vero cells) independently developed based on the core technology platform has completed clinical research work, and the target is to obtain the production batch number in 2022 and pass the GMP acceptance. On the one hand, Chengda Bio has accelerated the expansion of its product line, supplemented the conventional vaccine varieties at a high starting point, and actively promoted the development of multi-linked multi-valent vaccines and innovative vaccines around the country's expansion of the immunization program vaccine supply system. Chengda Bio has always adhered to the values ​​of “integrity and responsibility”, established brand awareness and reputation in both domestic and international markets, adhered to the “international level, domestic leading” product positioning, and strived to become trustworthy and respectful in the industry. A company with significant influence.

Changchun Keygen Biological Products Co. Ltd. engages in the research and development of pharmaceutical products. The company main products are live attenuated measles and varicella vaccine, chickenpox vaccine and other related products. The company was founded in December 2003 and is headquartered in Changchun, China.

Luoyang Saiao Bioengineering Technology Co., Ltd., established on 2018-10-08, Business scope includes cell culture media,Development of cell culture consumables and cell culture equipment,production and sales;Biochemical reagents,Development of biological reagents and bioseparation media,production and sales;Bioengineering project technology development,Technical consultation and transfer of technological achievements;Import and export of goods and technology.

Luoyang Fudao Biotechnology Co., Ltd., established on 2014-09-05, Business scope includes general items:Sales of bio-based materials;Research and development of bio-based materials technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;New material technology research and development;Manufacturing of bio-based materials;New material technology promotion service;Biochemical product technology research and development;R&D and application of cell technology;Manufacturing of medical packaging materials;Manufacture of plastic crates and containers;Manufacturing of plastic products;Sales of plastic products;mold making;Mold Sales;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Engineering and Technology Research and Experimental Development;3DPrint base material sales;3Dprint service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Import and export;Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Shenyang Xinbang Intelligent Equipment Co., Ltd., established on 2020-07-24, Business scope includes licensed projects:Import and export,Import and export agency,Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Industrial Robot Manufacturing,Pharmaceutical special equipment manufacturing,Packaging special equipment manufacturing,Material Handling Equipment Manufacturing,Intelligent storage equipment sales,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,Internet of Things Technology Services,Machinery sales,Electrical Equipment Sales,Communication equipment sales,Instrument sales,Intelligent robot sales,Servo Control Mechanism Sales,Sales of packaging materials and products,Internet equipment sales,Sales of pneumatic power machinery and components,Industrial automatic control system device sales,Sales of industrial control computers and systems,Industrial Robot Sales,General equipment manufacturing(Does not include special equipment manufacturing),Smart Material Handling Equipment Sales,software development,software sales,Material Handling Equipment Sales,Mechanical Parts,Parts processing(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nanjing Aierpu Zaisheng Medical Technology Co. Ltd. is a company headquartered in Nanjing, China, that develops pluripotent stem cell technology to regenerate myocardial, liver, nerve and other tissues and organs. The firm was founded in 2016 by Jia Xian Wang.

Shanghai Qingsai Biotechnology Co., Ltd., established on 2017-04-19, The scope of business includes engaging in technology development in the field of biotechnology,technical consulting,Technical Services,pharmaceutical production,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Foshan Huiteng Biotechnology Co., Ltd., established on 2018-03-07, Business scope includes biotechnology extension services;Agricultural Science Research and Experimental Development;Manufacturing of food and feed additives;Wholesale Salt and Condiments(food additives);Livestock and Fishery Feed Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanghai Flyman Information Technology Co., Ltd., established on 2019-05-21, Business scope includes information technology,medical technology,Biological Technology,Optoelectronics Technology,Technology development in the field of computer science and technology,technology transfer,technical consulting,Technical Services,medical instruments,Instrumentation,Sales of computer hardware and software,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Changchun Biological Products Research Institute Co., Ltd., established on 1985-12-05, Business scope includes manufacturing of biological products,distribution;Operate the research and development and production export business of the Institute and its directly affiliated enterprises, as well as the import business of raw and auxiliary materials, machinery, equipment, instruments, instruments and spare parts required for production and scientific research.;road general cargo transportation;Dedicated transport of goods;Cold chain transportation(Refrigeration and preservation equipment);Biotechnology Consulting,Technical Services;pharmaceutical equipment,Cold storage and workshop leasing services;Warehousing Services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)*

Shanghai WuXi Biopharmaceutical Technology Co., Ltd., established on 2020-09-14, Business scope includes general items:Engaged in technical services in the field of medical technology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(human stem cells,Except for the development and application of genetic diagnosis and treatment technology);business management;Information Consulting Service(Not including licensing information consulting services);Health Consulting Services(Does not include medical services,Internet value-added services);Technology Import and Export;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Luoyang Fudao Cell Engineering Technology Co., Ltd., established on 2020-07-16, Business scope includes cell culture flasks,Development of polymer materials such as cell factories and cell culture carriers,Manufacturing and Sales;Development of engineering technologies related to cell culture,consult,comminicate,transfer,Promotion service;medical supplies,sanitary material,medical materials,Manufacture and sales of medical polymer materials;Engaged in the import and export of goods or technology.

Shanghai Hougao Scientific Instrument Co., Ltd., established on 2007-11-29, The business scope includes instrumentation,Communication equipment and related products,Wujinjiaodian,Equipment,computer,Software and Auxiliary Equipment,electronic product,household appliances,Chemical raw materials(In addition to dangerous goods),Daily necessities,metallic material,clothing,sale of furniture,engaged in biology,chemical industry,Technology development in the field of network technology,Technical Services,technology transfer,technical consulting,business inquiries,Investment Advisory(Consulting projects except brokerage),translation service,Engaged in the import and export of goods and technology(involving administrative licensing,The operating permit). [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Provides fully integrated contract manufacturing services to medical device manufacturers worldwide in the cardiovascular, endoscopy and orthopedic markets

Tianjin Saieryuan Biotechnology Co., Ltd., established on 2017-09-28, Business scope includes biotechnology development,transfer,consult,Serve,biological culture equipment,plastic products,Medical Instrument Manufacturing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Koninklijke DSM NV engages in the manufacture and sale of nutritional and pharmaceutical ingredients, and industrial chemicals. It operates through the following segments: Nutrition, Materials, Innovation Center, and Corporate Activities. The Nutrition segment serves the global industries for animal feed, food and beverage, pharmaceuticals, infant nutrition, dietary supplements, and personal care. The Materials segment deals with specialty plastics, which are used in components for the electrical and electronics, automotive, flexible food-packaging, and consumer goods industries. The Innovation Center segment focuses on innovation and the growth of DSM's existing core business through adjacent technologies. The Corporate Activities segment consists of operating and service activities as well as other several costs. The company was founded in 1902 and is headquartered in Herleen, the Netherlands.

Dibier Pharmaceutical Equipment (Shanghai) Co., Ltd., established on 2020-02-11, Business scope includes pharmaceutical equipment,automation equipment,laboratory equipment design,manufacture,processing,Install,repair,Bioreactor Manufacturing,processing,Metal Products Processing,engaged in medical technology,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,computer software development,metal products,computer,Software and Auxiliary Equipment,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),automation equipment,Instrumentation,Office Supplies,Electronic Component,metallic material,Wholesale of communication equipment,retail,Own Equipment Rental,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.]

Dibier Bioengineering (Shanghai) Co., Ltd., established on 2012-05-16, Business scope includes licensed projects:Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:Engaged in technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer,experiment apparatus(Except special,measuring tools),Pharmaceutical equipment(Licensed professional equipment not included),Industrial Intelligent Equipment,R&D of metal products,production and sales,Industrial Automation Control System Design,manufacture,computer software development,computer,Software, hardware and accessories,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),automation equipment,Instrumentation,Office Supplies,Electronic Component,metallic material,Communication equipment sales,Own Equipment Rental.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)